INSULET CORPORATION Research and Development Expense
INSULET CORPORATION (PODD) reported Research and Development Expense of $88.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- INSULET CORPORATION research and development expense for the quarter ending 2026-06-30 was $88.10M, a 20.03% increase year-over-year.
- INSULET CORPORATION research and development expense for the quarter ending 2026-03-31 was $89.70M, a 50.50% increase year-over-year.
- INSULET CORPORATION research and development expense for the quarter ending 2025-12-31 was $90.90M, a 50.00% increase year-over-year.
- INSULET CORPORATION research and development expense for the quarter ending 2025-09-30 was $77.20M, a 40.62% increase year-over-year.
- INSULET CORPORATION research and development expense for fiscal 2025 was $301.10M, a 37.11% increase from fiscal 2024.
- INSULET CORPORATION research and development expense for fiscal 2024 was $219.60M, a 7.12% increase from fiscal 2023.
- INSULET CORPORATION research and development expense for fiscal 2023 was $205.00M, a 13.76% increase from fiscal 2022.
- INSULET CORPORATION research and development expense for fiscal 2022 was $180.20M, a 12.55% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $88.10M 10-Q · filed 2026-08-05 | $177.80M 10-Q · filed 2026-08-05 | $268.70M derived: sum of 3 quarters · filed 2026-08-05 | $345.90M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $89.70M 10-Q · filed 2026-05-06 | $180.60M derived: sum of 2 quarters · filed 2026-05-06 | $257.80M derived: sum of 3 quarters · filed 2026-05-06 | $331.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $90.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $168.10M derived: sum of 2 quarters · filed 2026-02-18 | $241.50M derived: sum of 3 quarters · filed 2026-08-05 | $301.10M 10-K · filed 2026-02-18 | ||||
| 2025-09-30 | $77.20M 10-Q · filed 2025-11-06 | $150.60M derived: sum of 2 quarters · filed 2026-08-05 | $210.20M 10-Q · filed 2025-11-06 | $270.80M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $73.40M 10-Q · filed 2026-08-05 | $133.00M 10-Q · filed 2026-08-05 | $193.60M derived: sum of 3 quarters · filed 2026-08-05 | $248.50M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $59.60M 10-Q · filed 2026-05-06 | $120.20M derived: sum of 2 quarters · filed 2026-05-06 | $175.10M derived: sum of 3 quarters · filed 2026-05-06 | $229.00M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $60.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $115.50M derived: sum of 2 quarters · filed 2026-02-18 | $169.40M derived: sum of 3 quarters · filed 2026-02-18 | $219.60M 10-K · filed 2026-02-18 | ||||
| 2024-09-30 | $54.90M 10-Q · filed 2025-11-06 | $108.80M derived: sum of 2 quarters · filed 2025-11-06 | $159.00M 10-Q · filed 2025-11-06 | $201.00M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-06-30 | $53.90M 10-Q · filed 2025-08-07 | $104.10M 10-Q · filed 2025-08-07 | $146.10M derived: sum of 3 quarters · filed 2026-02-18 | $203.90M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-03-31 | $50.20M 10-Q · filed 2025-05-09 | $92.20M derived: sum of 2 quarters · filed 2026-02-18 | $150.00M derived: sum of 3 quarters · filed 2026-02-18 | $205.10M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2023-12-31 | $42.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $99.80M derived: sum of 2 quarters · filed 2026-02-18 | $154.90M derived: sum of 3 quarters · filed 2026-02-18 | $205.00M 10-K · filed 2026-02-18 | ||||
| 2023-09-30 | $57.80M 10-Q · filed 2024-11-08 | $112.90M derived: sum of 2 quarters · filed 2024-11-08 | $163.00M 10-Q · filed 2024-11-08 | $212.50M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $55.10M 10-Q · filed 2024-08-09 | $105.20M 10-Q · filed 2024-08-09 | $154.70M derived: sum of 3 quarters · filed 2025-02-21 | $199.70M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $50.10M 10-Q · filed 2024-05-10 | $99.60M derived: sum of 2 quarters · filed 2025-02-21 | $144.60M derived: sum of 3 quarters · filed 2025-02-21 | $187.20M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $49.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $94.50M derived: sum of 2 quarters · filed 2025-02-21 | $137.10M derived: sum of 3 quarters · filed 2025-02-21 | $180.20M 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | $45.00M 10-Q · filed 2023-11-03 | $87.60M derived: sum of 2 quarters · filed 2023-11-03 | $130.70M 10-Q · filed 2023-11-03 | $172.50M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $42.60M 10-Q · filed 2023-08-09 | $85.70M 10-Q · filed 2023-08-09 | $127.50M derived: sum of 3 quarters · filed 2024-02-23 | $165.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $43.10M 10-Q · filed 2023-05-05 | $84.90M derived: sum of 2 quarters · filed 2024-02-23 | $122.40M derived: sum of 3 quarters · filed 2024-02-23 | $162.50M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $41.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $79.30M derived: sum of 2 quarters · filed 2024-02-23 | $119.40M derived: sum of 3 quarters · filed 2024-02-23 | $160.10M 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | $37.50M 10-Q · filed 2022-11-04 | $77.60M derived: sum of 2 quarters · filed 2022-11-04 | $118.30M 10-Q · filed 2022-11-04 | $156.60M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $40.10M 10-Q · filed 2022-08-05 | $80.80M 10-Q · filed 2022-08-05 | $119.10M derived: sum of 3 quarters · filed 2023-02-24 | $157.90M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-03-31 | $40.70M 10-Q · filed 2022-05-06 | $79.00M derived: sum of 2 quarters · filed 2023-02-24 | $117.80M derived: sum of 3 quarters · filed 2023-02-24 | $152.00M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2020-12-31 | $38.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $77.10M derived: sum of 2 quarters · filed 2023-02-24 | $111.30M derived: sum of 3 quarters · filed 2023-02-24 | $146.80M 10-K · filed 2023-02-24 | ||||
| 2020-09-30 | $38.80M 10-Q · filed 2021-11-05 | $73.00M derived: sum of 2 quarters · filed 2021-11-05 | $108.50M 10-Q · filed 2021-11-05 | $144.00M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $34.20M 10-Q · filed 2021-08-06 | $69.70M 10-Q · filed 2021-08-06 | $105.20M derived: sum of 3 quarters · filed 2022-02-24 | $136.50M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $35.50M 10-Q · filed 2021-05-07 | $71.00M derived: sum of 2 quarters · filed 2022-02-24 | $102.30M derived: sum of 3 quarters · filed 2022-02-24 | $135.30M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $35.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $66.80M derived: sum of 2 quarters · filed 2022-02-24 | $99.80M derived: sum of 3 quarters · filed 2022-02-24 | $132.30M 10-K · filed 2022-02-24 | $129.70M 10-K · filed 2020-02-26 | |||
| 2019-09-30 | $31.30M 10-Q · filed 2020-11-05 | $30.78M 10-Q · filed 2019-11-06 | $64.30M derived: sum of 2 quarters · filed 2020-11-05 | $96.80M 10-Q · filed 2020-11-05 | $95.00M 10-Q · filed 2019-11-06 | $130.20M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-06-30 | $33.00M 10-Q · filed 2020-08-07 | $32.26M 10-Q · filed 2019-08-06 | $65.50M 10-Q · filed 2020-08-07 | $64.22M 10-Q · filed 2019-08-06 | $98.90M derived: sum of 3 quarters · filed 2021-02-24 | $121.23M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-03-31 | $32.50M 10-Q · filed 2020-05-08 | $31.95M 10-Q · filed 2019-05-03 | $65.90M derived: sum of 2 quarters · filed 2021-02-24 | $88.23M derived: sum of 3 quarters · filed 2021-02-24 | $107.03M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $33.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $55.73M derived: sum of 2 quarters · filed 2021-02-24 | $74.53M derived: sum of 3 quarters · filed 2021-02-24 | $94.80M 10-K · filed 2021-02-24 | $88.61M 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $22.34M 10-Q · filed 2019-11-06 | $21.76M 10-Q · filed 2018-11-02 | $41.14M derived: sum of 2 quarters · filed 2019-11-06 | $61.40M 10-Q · filed 2019-11-06 | $60.09M 10-Q · filed 2018-11-02 | $81.43M derived: sum of 4 quarters · filed 2020-02-26 | ||
| 2018-06-30 | $18.80M 10-Q · filed 2019-08-06 | $18.42M 10-Q · filed 2018-08-02 | $39.07M 10-Q · filed 2019-08-06 | $38.33M 10-Q · filed 2018-08-02 | $59.10M derived: sum of 3 quarters · filed 2020-02-26 | $79.24M derived: sum of 4 quarters · filed 2020-02-26 | ||
| 2018-03-31 | $20.27M 10-Q · filed 2019-05-03 | $19.91M 10-Q · filed 2018-05-04 | $40.30M derived: sum of 2 quarters · filed 2020-02-26 | $60.44M derived: sum of 3 quarters · filed 2020-02-26 | $78.47M derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2017-12-31 | $20.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $40.17M derived: sum of 2 quarters · filed 2020-02-26 | $58.20M derived: sum of 3 quarters · filed 2020-02-26 | $75.70M 10-K · filed 2020-02-26 | $74.45M 10-K · filed 2018-02-22 | |||
| 2017-09-30 | $20.14M 10-Q · filed 2018-11-02 | $38.17M derived: sum of 2 quarters · filed 2018-11-02 | $55.67M 10-Q · filed 2018-11-02 | $71.70M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $18.03M 10-Q · filed 2018-08-02 | $35.53M 10-Q · filed 2018-08-02 | $51.56M derived: sum of 3 quarters · filed 2019-02-26 | $65.30M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $17.50M 10-Q · filed 2018-05-04 | $33.53M derived: sum of 2 quarters · filed 2019-02-26 | $47.27M derived: sum of 3 quarters · filed 2019-02-26 | $60.22M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $16.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $29.77M derived: sum of 2 quarters · filed 2019-02-26 | $42.72M derived: sum of 3 quarters · filed 2019-02-26 | $55.71M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $13.73M 10-Q · filed 2017-11-03 | $26.69M derived: sum of 2 quarters · filed 2017-11-03 | $39.68M 10-Q · filed 2017-11-03 | $52.57M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $12.95M 10-Q · filed 2017-08-04 | $25.94M 10-Q · filed 2017-08-04 | $38.84M derived: sum of 3 quarters · filed 2018-02-22 | $48.87M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $12.99M 10-Q · filed 2017-05-09 | $25.89M derived: sum of 2 quarters · filed 2018-02-22 | $35.92M derived: sum of 3 quarters · filed 2018-02-22 | $47.99M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $22.93M derived: sum of 2 quarters · filed 2018-02-22 | $35.00M derived: sum of 3 quarters · filed 2018-02-22 | $43.21M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $10.04M 10-Q · filed 2016-11-04 | $22.10M derived: sum of 2 quarters · filed 2016-11-04 | $30.31M 10-Q · filed 2016-11-04 | $37.60M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $12.07M 10-Q · filed 2016-08-04 | $20.28M 10-Q · filed 2016-08-04 | $27.56M derived: sum of 3 quarters · filed 2017-02-28 | $34.72M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $8.21M 10-Q · filed 2016-04-29 | $15.49M derived: sum of 2 quarters · filed 2017-02-28 | $22.65M derived: sum of 3 quarters · filed 2017-02-28 | $29.33M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $7.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $14.44M derived: sum of 2 quarters · filed 2017-02-28 | $21.12M derived: sum of 3 quarters · filed 2017-02-28 | $27.90M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $7.16M 10-Q · filed 2015-11-06 | $13.84M derived: sum of 2 quarters · filed 2015-11-06 | $20.61M 10-Q · filed 2015-11-06 | $27.04M derived: sum of 4 quarters · filed 2016-09-06 | ||||
| 2014-06-30 | $6.68M 10-Q · filed 2015-08-12 | $13.46M 10-Q · filed 2015-08-12 | $19.88M derived: sum of 3 quarters · filed 2016-09-06 | $25.65M derived: sum of 4 quarters · filed 2016-09-06 | ||||
| 2014-03-31 | $6.78M 10-Q · filed 2015-04-30 | $13.20M derived: sum of 2 quarters · filed 2016-09-06 | $18.97M derived: sum of 3 quarters · filed 2016-09-06 | $24.15M derived: sum of 4 quarters · filed 2016-09-06 | ||||
| 2013-12-31 | $6.42M derived: 8-K 12 month − 10-Q 9 month · filed 2016-09-06 | $12.20M derived: sum of 2 quarters · filed 2016-09-06 | $17.37M derived: sum of 3 quarters · filed 2016-09-06 | $21.77M 8-K · filed 2016-09-06 | ||||
| 2013-09-30 | $5.77M 10-Q · filed 2014-11-05 | $10.95M derived: sum of 2 quarters · filed 2014-11-05 | $15.34M 10-Q · filed 2014-11-05 | $21.19M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $5.17M 10-Q · filed 2014-08-07 | $9.57M 10-Q · filed 2014-08-07 | $15.42M derived: sum of 3 quarters · filed 2015-02-26 | $21.98M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $4.40M 10-Q · filed 2014-05-07 | $10.24M derived: sum of 2 quarters · filed 2015-02-26 | $16.80M derived: sum of 3 quarters · filed 2015-02-26 | $23.32M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $5.85M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $12.41M derived: sum of 2 quarters · filed 2015-02-26 | $18.93M derived: sum of 3 quarters · filed 2015-02-26 | $24.36M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $6.56M 10-Q · filed 2013-11-07 | $13.08M derived: sum of 2 quarters · filed 2013-11-07 | $18.51M 10-Q · filed 2013-11-07 | $24.32M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $6.52M 10-Q · filed 2013-08-08 | $11.95M 10-Q · filed 2013-08-08 | $17.76M derived: sum of 3 quarters · filed 2014-02-28 | $22.39M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $5.43M 10-Q · filed 2013-05-08 | $11.24M derived: sum of 2 quarters · filed 2014-02-28 | $15.87M derived: sum of 3 quarters · filed 2014-02-28 | $22.71M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $5.80M derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-02-28 | $10.44M derived: sum of 2 quarters · filed 2014-02-28 | $17.27M derived: sum of 3 quarters · filed 2014-02-28 | $21.86M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $4.64M 10-Q/A · filed 2013-02-28 | $11.47M derived: sum of 2 quarters · filed 2013-02-28 | $16.06M 10-Q/A · filed 2013-02-28 | $20.50M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $6.83M 10-Q/A · filed 2013-02-28 | $11.42M 10-Q/A · filed 2013-02-28 | $15.86M derived: sum of 3 quarters · filed 2013-02-28 | $19.56M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $4.59M 10-Q/A · filed 2013-02-28 | $9.03M derived: sum of 2 quarters · filed 2013-02-28 | $12.72M derived: sum of 3 quarters · filed 2013-02-28 | $17.31M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $4.44M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-02-28 | $8.14M derived: sum of 2 quarters · filed 2013-02-28 | $12.72M derived: sum of 3 quarters · filed 2013-02-28 | $16.57M 10-K/A · filed 2013-02-28 | ||||
| 2010-09-30 | $3.70M 10-Q · filed 2011-11-08 | $8.28M derived: sum of 2 quarters · filed 2011-11-08 | $12.13M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $4.58M 10-Q · filed 2011-08-09 | $8.43M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $13.23M 10-K/A · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |